Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.2.7 (
heparinase
)
1,270
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
While extracellular acidification within solid tumors is well-documented, how reduced pH impacts regulation of insulin-like growth factor-I (IGF-I) has not been studied extensively. Because IGF-I receptor binding is affected by IGF binding proteins (IGFBPs), we examined how pH impacted
IGFBP-3
regulation of IGF-I. IGF-I binding in the absence of
IGFBP-3
was diminished at reduced pH. Addition of
IGFBP-3
reduced IGF-I cell binding at pH 7.4 but increased surface association at pH 5.8. This increase in IGF-I binding at pH 5.8 corresponded with an increase in
IGFBP-3
cell association. This, however, was not due to an increase in affinity of
IGFBP-3
for heparin at reduced pH although both
heparinase
III treatment and heparin addition reduced
IGFBP-3
enhancement of IGF-I binding. An increase in IGF-I binding to
IGFBP-3
, though, was seen at reduced pH using a cell-free assay. We hypothesize that the enhanced binding of IGF-I at pH 5.8 is facilitated by increased association of
IGFBP-3
at this pH and that the resulting cell associated IGF-I is
IGFBP-3
and not IGF-IR bound. Increased internalization and nuclear association of IGF-I at pH 5.8 in the presence of
IGFBP-3
was evident, yet cell proliferation was reduced by
IGFBP-3
at both pH 5.8 and 7.4 indicating that
IGFBP-3
-cell associated IGF-I does not signal the cell to proliferate and that the resulting transfer of bound IGF-I from IGF-IR to
IGFBP-3
results in diminished proliferation. Solution binding of IGF-I by
IGFBP-3
is one means by which IGF-I-induced proliferation is inhibited. Our work suggests that an alternative pathway exists by which IGF-I and
IGFBP-3
both associate with the cell surface and that this association inhibits IGF-I-induced proliferation.
...
PMID:Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment. 1174 93